Published in:
01-02-2006 | Letter to the Editors
Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter
Authors:
Francois Cachat, Daniel Bardy, Claudine Durussel, Ermindo Di Paolo
Published in:
Pediatric Nephrology
|
Issue 2/2006
Login to get access
Abstract
Alteplase has been shown to be effective in preventing central venous access clotting in patients on hemodialysis. Because of a high phosphorus content in its excipient, it can inadvertently contaminate blood samples, leading the physician in care of the patient to erroneously increase dialysis time or change diet in order to control the pseudo-hyperphosphatemia.